EichorEICHOR
Location: Geelong Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Geelong

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
NA · Pain Matrix · Saluda Medical Pty Ltd · NCT04662905Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Barwon Health Geelong Hospital · Amgen · NCT07037433ROADMAP Clinical Trial
Phase 4 · University Hospital Geelong · University of Newcastle, Australia · NCT06771050A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Barwon Health /ID# 241920 · AbbVie · NCT04928846Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r
Phase 1 · Barwon Health - Andrew Love Cancer Centre · Imugene Limited · NCT03666000Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial
Phase 3 · Barwon Health - University Hospital Geelong · Monash University · NCT05072314A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Dar
Phase 3 · Barwon Health - University Hospital Geelong · Janssen Research & Development, LLC · NCT05552222The Early Valve Replacement in Severe ASYmptomatic Aortic Stenosis Study
NA · University Hospital Geelong · University of Leicester · NCT04204915Tiragolumab and Atezolizumab in Advanced Pan-cancer Patients
Phase 2 · Barwon Health · Omico · NCT06003621Telacebec (T) Treatment in Adults With Buruli Ulcer (BU). (TREAT BU)
Phase 2 · Barwon Health · Barwon Health · NCT06481163Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment
Phase 4 · Dr David Fabinyi · Center for Eye Research Australia · NCT06587945A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Phase 3 · Barwon Health · Eli Lilly and Company · NCT07392190A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D
Phase 2 · Site Number - 5104 · Immunovant Sciences GmbH · NCT07018323PRIORITY-CONNECT 2 Trial
NA · University Hospital Geelong (Barwon Health) · Surgical Outcomes Research Centre (SOuRCe) · NCT06976710The EXCEL Registry of Patients Requiring ECMO
Phase N/A · University Hospital Geelong · Australian and New Zealand Intensive Care Research Centre · NCT03793257Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Phase 3 · Research Site · AstraZeneca · NCT06307652MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Ha
Phase 3 · Barwon Health · Pfizer · NCT06152575Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PI
Phase 3 · Barwon Health · Relay Therapeutics, Inc. · NCT06982521A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment in Adult Patients With Multipl
Phase 3 · Barwon Health, University Hospital Geelong · European Myeloma Network B.V. · NCT06932562Platform of Randomized Adaptive Clinical Trials in Critical Illness
NA · University Hospital Geelong · University Health Network, Toronto · NCT05440851National Robotics-Assisted Radical Prostatectomy Database
Phase N/A · Barwon health · Melbourne Health · NCT06279260A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone
Phase 3 · University Hospital Geelong · Regeneron Pharmaceuticals · NCT05730036A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirv
Phase 2 · Barwon Health /ID# 277297 · AbbVie · NCT07059845Improving Early Intervention in Hearing Impaired Children Using Functional Near-Infrared Spectroscopy (fNIRS)
NA · Barwon Health · The Bionics Institute of Australia · NCT05847426Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Phase 3 · University Hosptial Geelong · UMC Utrecht · NCT02735707Staphylococcus Aureus Network Adaptive Platform Trial
Phase 4 · Barwon Health - University Hospital Geelong · University of Melbourne · NCT05137119Silexan in the Treatment Of Posttraumatic Stress Disorder Trial
Phase 3 · Deakin University · Deakin University · NCT06412757A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Phase 3 · Adrian Costa Clinical Trials Centre · Novo Nordisk A/S · NCT07567001A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 · Kivu Trial Site · Kivu Bioscience Inc. · NCT07229313A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and N
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT06256588
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.